Gần 70% công ty xuất khẩu của Anh chưa sẵn sàng cho “Brexit cứng”

Theo số liệu công bố mới nhất của Cơ quan Ngân sách và Hải quan Anh (HMRC), hiện chỉ có 70.000 trên tổng số khoảng 240.000 doanh nghiệp đã đăng ký các thủ tục cần thiết để có thể tiếp tục làm ăn với Liên minh châu Âu (EU) sau khi Anh rời khỏi khối (Brexit). Những công ty chưa đăng ký đa phần là vừa và nhỏ.

QGQ7P+G6o+G7gX3DtMO04buqJuG7jeG7kMSR4buR4buB4bqvJiNDOeG7gz88OuG7rD/huqPDrOG7g2M/4buRdT904buTOOG7kT/hur9kw6Hhu5M/4bqjxqF9P8aw4buDZD/huqNk4budfT/DtDbhu4M/w7Rd4buDYz/huqNk4buFPybhuqDDteG6r3TEkeG7kT/huqPhu6Phu4NjJkAvZDsjQOG7jT/huqPhu4F9w7TDtOG7qibhu41E4bqvfcOjJiPhu5Bk4bqv4buFP8O04buLP+G7gcSR4bqt4buTP+G6o8Os4buDYz/huqHhu4s/4buHbcSRP+G7g2Q44buRP+G6o8ahfT/huqJsP+G7j+G7k33hu4M/4buCYzfhu4M/w7Rb4bqjZD9yXT9EIMSRP+G7j+G7k33hu4M/xrDhu4NkP+G7tkThu4bDleG6ouG7uMOdP2TEkeG6reG7gz/huqNk4bq7P+G6o2Y/PDrhu7I6Ojo/4buRw7XDouG7gz/hu5Fq4buDYz/DtOG7iz/hur9k4buFIOG7g2M/LCE64buyOjo6P8Oj4buFfeG7g2Q/4buDY2TEkeG6reG7jT/EgzA/xIMx4buDYz/hur/Duj/huqNb4bqjP+G7kWTGoT/hu5Hhu5fhuqM/4bqjOeG7gz/hu5FkxJHhuqXhu5E/xIPhuqk/4bqjZj/hu5Fk4bqpP+G7kcSR4bql4buNP+G7keG7l+G6oz/hu4Fd4buHPzHhu4M/cm3EkT/hu4DEkcOi4buDP+G7h8SR4buDZD/huqNkN+G7kz/hu7Xhu5M/4bu24bqu4buS4bu4P8O0feG7kz/hur9kxJE/xrDhu4NkP8O1bsSRP+G6v2RpxJE/4bq/ZOG7i8SRP+G7tuG6oMO14bqvdMSR4buR4bu44buyP+G7gmRx4buDYz/huqPDrOG7g2M/4buRdT/huqNk4budfT/EgzHhu4NjP+G6v8O6P8SDfT/hu41kOeG7gz/hu4FdP3Lhu599P3JdP+G7g2Rp4buyQC/hu40jQOG7jT/huqPhu4F9w7TDtOG7qibhu43huqDhu4XDo3UmI0DEkeG7h2M/4bqj4buBfcO0w7Thu6om4bqj4buHw7Qt4buNZOG7heG7keG7hSY/4buRxJHhu5Hhu4Hhuq/hu6omQznhu4M/PDrhu6w/4bqjw6zhu4NjP+G7kXU/dOG7kzjhu5E/4bq/ZMOh4buTP+G6o8ahfT/GsOG7g2Q/4bqjZOG7nX0/w7Q24buDP8O0XeG7g2M/4bqjZOG7hT8m4bqgw7Xhuq90xJHhu5E/4bqj4buj4buDYyY/ZMOp4buDZD8g4buDZD87Jj/DtMO14bqj4buqJi8v4bqj4buy4bqhfeG7heG7kWR94buDZGThu4V94buycuG7gy/EkeG7h2Mvw6Phuq/DtOG6v+G7keG7heG7jS/hu4Phuq9zw7QvO3suOy87PDzDoyE6eyE+ITrhu5Epezo+4buBO+G7snPhuq/huqHhu40mP33hu4Hhu5Hhu6omQznhu4M/PDrhu6w/4bqjw6zhu4NjP+G7kXU/dOG7kzjhu5E/4bq/ZMOh4buTP+G6o8ahfT/GsOG7g2Q/4bqjZOG7nX0/w7Q24buDP8O0XeG7g2M/4bqjZOG7hT/igJzhuqDDteG6r3TEkeG7kT/huqPhu6Phu4Nj4oCdJj/Do33hu5F9LeG7jWThu4Xhu5Hhu4Ut4buFw7XEkWPEkeG7g33hu4Etw7TDteG6o+G7qiZk4buR4buR4buNw7RYLy/huqPDo+G7g8SR4buHY+G7snLEkeG6r+G7keG7g33hu4fhu43hu4Hhu5PDtOG7snLhu4Mv4buRKSw6L+G7k+G7jeG7geG7hX3Do+G6r8OjL+G6oeG7hcOq4buF4bq/fS8sOjt7Xzo+Xzo+L8Oj4buFcuG6r8O14buN4buFw7Xhu5Hhu4194buyw6rhu41jJj8vI+G6oiDhu4NjP8OD4buFcuG6r8O1P+G6o8ahfT/GsOG7g2Thu7I/4bu24but4buDZFg/4buMxrDhu7hAL+G7jSNA4buNP+G6o+G7gX3DtMO04buqJuG7jeG6oOG7hcOjdSYjROG7hsOV4bqiP+G6o2Thu4U/4bqhxJHhuqXhu5E/ZMSR4bqt4buDP8O04buLP8Oj4buFfeG7g2Q/4buDY2TEkeG6reG7jT/EgzA/4buRZOG7oeG6oz9kxJHhuq3hu4M/xIPGoT/hu4NkceG7g2M/4buRZMahP+G7keG7l+G6oz/huqM54buDP+G7kWTEkeG6peG7kT/huqNkxJHhuqXhu4c/PCjhu6w/4bqjW+G6oz9k4buFIuG7kT/Eg8Sp4buDYz9jxJF94buFP+G7kWThu51s4buDYz9jxJFxfT/GsOG7g2Q/cl0/4bqu4buS4buyP+G7kOG7k3U/4buDZMSRw6Lhu4PDnT/hu5Fk4bqv4buFP8O04buLP+G7gcSR4bqt4buTP+G6o8ahfT/DlOG6v3U/4buC4bqvc8O0w50/csOg4buDP+G6o2fhu4M/4buDZMSR4bqn4buTP+G6o8Os4buDYz/hu5F1P+G7gW3hu4PDnT/Eg30/w7Thu4s/4buBXT/hu5HDteG7heG7g2M/4buB4bq94buDZD9y4buh4bqjP+G7kWThu6HhuqM/4buNZMOh4buHw50/4buHbcSRP+G6o2Thurs/4bqhMuG7kT/Egznhu5M/4bqjW+G6oz/hu5FkxqE/4buR4buX4bqjP8SDMeG7g2M/4bq/w7o/xIPhuqk/4bqjZj/hu5Fk4bqpP+G7kcSR4bql4buNP+G7keG7l+G6oz9k4buFIuG7kT/Eg8Sp4buDYz9jxJF94buFP+G7kWThu51s4buDYz9ybcSRP+G6ruG7kj/hu5HDteG7heG7g2M/4buRw7Xhu51u4buDYz9kb+G7jT8m4bqgw7Xhuq90xJHhu5E/4bqj4buj4buDYyY/LT/GsOG7g2Q/w7VuxJE/4bq/ZGnEkT/huq7hu5I/4buHXT/hur9kw6zhu4NjP8SDIuG7kT/hu5FkaX0/4buRZOG7k2Hhu4Phu7JAL+G7jSNA4buNP+G6o+G7gX3DtMO04buqJuG7jeG6oOG7hcOjdSYj4bqiZGXhu4NkP+G7jWTGoT/GsOG7g2Q/4bqjfeG7hz/hur/huqXhu5E/w7ThurU/4buRZOG7oeG6oz9kxJHhuq3hu4M/4buHxKnhu5E/4bqjZMSR4bql4buDP8Oj4bq54bqjZD/hu5HDteG7k3Xhuqfhu4M/4buRZMOs4buDYz/hu4Ft4buDP8SD4bqpP+G6v8Oi4buTP2NoxJE/4buHaMSRP+G7g2Phu51uxJE/cl0/Y8SRbcSRP8Oj4buFfeG7g2Q/4buDY2TEkeG6reG7jT/huqNk4buTw6Hhu4M/4bqh4bq5P+G6o2Thu4U/4buRw6nhu4NkP2Thu5Phu4vhu4NjPyY/4bqgw7Xhuq90xJHhu5E/4bqj4buj4buDYz8mP3Jd4buFP+G7keG7kznhu4M/4buRbcSR4buyP+G7kMO14buF4buDYz/hu5HDteG7nW7hu4NjP2Rv4buNP+G6oMO14bqvdMSR4buRP+G6v2TDrOG7g2M/4buRZGl9P+G7kWThu5Nh4buDw50/4bqjW+G6oz/huqPDrOG7g2M/4buRdT/huqPGoX0/xrDhu4NkP+G7gV3hu4c/MeG7gz9ybcSRP+G6ruG7kj/DtOG6tT/hu41kIMSRP+G6o2Thurnhu5M/4bq/xJHhuqnhu4c/w7Thu4Vb4buRP2QgxJE/4buP4buTfeG7gz9jxJHhu4vhu4NjP+G7g2Thu50/4bqu4buSP1vhu40/w6Phu5fhu4NjP8SD4buLxJE/cm3EkT/hu4NkceG7g2M/4buD4budbeG6oz/hur9kW+G6oz/hu5HDtcOi4buDP+G7kWThuqU/Y8SRbcSR4buyQC/hu40jQOG7jT/huqPhu4F9w7TDtOG7qibhu43huqDhu4XDo3UmI+G6olvhuqM/4bqjZOG7k3XDouG7gz9jxJF9P8Oj4buhP8SD4buFW+G7gz/DtOG7iz/hu4Hhu51v4buDYz/Eg2zhu4M/4bq/w6I/4bq/ZH3EkT9kIMSRP+G7j+G7k33hu4M/Y8SRcX0/xrDhu4NkP3JdP+G6ruG7kj/DtOG6tT/hu5Ex4buDYz8hP+G7gTnhu4M/w7Thu4U/cm3EkT9kxJHhuq3hu4M/4buDfXXDnT/hu4HDouG7gz/hur9k4buFIOG7g2M/LDo6P+G7kcO1xJHhuq3hu5M/4bq/w6I/4bq/ZH3EkT9kIMSRP+G7j+G7k33hu4M/4buHa8SRP+G7gzHhu4fhu7I/4buQZOG6r+G7hT/Do+G7oT/huqFb4buFP+G6o8ahfT/huqJkZeG7g2Q/4buNZMahP8aw4buDZMOdP+G7g+G6peG7kz90IHU/w7V9P+G6oMO14bqvdMSR4buRP+G6v2TDrOG7g2M/4buRZGl9P+G7kWThu5Nh4buDw50/4bq/ZCA/4buDMeG7g2M/Y8SRfeG7hT/hu5Fk4budbOG7g2M/Y8SRW+G7gz/Eg+G7hSLhu4M/4buRIsSRP+G6v2Thu5M/cuG7oeG6oz/huqMg4buDYz/Dg+G7hXLhuq/DtT/DtOG6tT/hur/hurHhu4U/w6NdxJE/4buRbcSRPyk/4buRZFvhu4Nj4buyQC/hu40jQOG7jT/huqPhu4F9w7TDtOG7qibhu43huqDhu4XDo3UmI0Thu4bDleG6oj/EgzA/xIPhu4nhu4NjP8O6P+G6o2Thu4U/4buNZOG6seG7jT/huqNb4bqjP+G6o8Os4buDYz/hu5F1P+G6o2Y/4buRZOG6qT/DtHA/w6Phu5fhu4NjP+G7g2Rx4buDYz/hu5FkaX0/4buRZOG7k2Hhu4M/xIM04bqjP+G6ocSR4bqt4buRP+G7kcO14buF4buDYz9jxJF9xJE/xIPhu4Ui4buDP+G6o2Thu5N14bqp4buDP+G7kcSR4bql4buN4buyP+G7gmRx4buDYz/huqPDrOG7g2M/4buRdT/EgzHhu4NjP+G6v8O6P+G7kWTGoT/hu5Hhu5fhuqM/xINs4buDP2PEkSDhu4M/ZGZ9P+G6o2Thu5N14bqp4buDP+G7kcSR4bql4buNP8O04bq1P+G6o2Y/4buRZG7EkT9kIuG7gz8pP+G7kWRb4buDYz/Eg+G6qT/hu4Fd4buHP+G7kWTGoT/hu5Hhu5fhuqM/4bq/w6I/4bq/ZH3EkT9kIMSRP+G7j+G7k33hu4M/cl0/4buRZOG7k+G6pT9jxJFbP+G7kcO14bq5P2PEkX0/4buRMeG7g2M/4bqjZOG7hT9kXeG7g2M/ZGZ94buyL+G7skAv4buNI0Dhu40/4bqj4buBfcO0w7Thu6om4buNxrDhu5Phu5Fk4buFw7UmI+G7tuG7kOG7kFRS4buCL1LEkeG6r+G7keG7g33hu4cr4bu4QC/hu40j

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh